Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Raia Drogasil S.A. logo
RADL3.SA
Raia Drogasil S.A.
13:12:18
16.54 R$
0.0000 (%0.00)
Previous Close: 16.55
Day Low₺16.42
Day High₺16.63
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

RADL3.SA: Raia Drogasil S.A. Financials

Raia Drogasil S.A. Income Statement

Total revenue
Net income
Gross margin TTM
24.75%
Operating margin TTM
5.96%
Net profit margin TTM
2.93%
Return on investment TTM
17.71%
Period end31/12/202531/12/202431/12/202331/12/2022
Total revenue44,250,449,00038,864,455,00033,973,790,00029,067,380,000
Operating income2,637,425,0002,367,171,0002,080,489,0001,839,324,000
Net income1,296,861,0001,197,694,0001,054,973,000996,112,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Total revenue44,250,449,00038,864,455,00033,973,790,00029,067,380,000
Cost of revenue33,298,605,00027,314,740,00023,766,426,00020,257,912,000
Gross profit10,951,844,00011,549,715,00010,207,364,0008,809,468,000
Research and development expenses0000
General and administrative expenses1,570,393,0001,567,110,0001,503,526,0001,249,847,000
Selling and marketing expenses8,719,372,0007,627,561,0006,689,275,0005,805,992,000
Selling, general and administrative expenses8,276,721,0009,194,671,0008,192,801,0007,055,839,000
Other expenses37,698,000-12,127,000-65,926,000-85,695,000
Operating expenses8,314,419,0009,182,544,0008,126,875,0006,975,303,000
Cost and expenses41,613,024,00036,497,284,00031,893,301,00027,228,056,000
Net interest income-1,053,937,000-754,880,000-691,879,000-673,914,000
Interest income19,399,00036,067,00045,908,000-114,691,000
Interest expense1,073,336,000790,947,000737,787,000559,223,000
Depreciation and amortization2,013,044,000911,965,000797,690,000700,166,000
EBITDA4,650,469,0003,140,395,0002,752,170,0002,452,598,000
EBIT2,637,425,0002,228,430,0001,954,480,0001,752,432,000
Non-operating income (excl. interest)134,917,000138,741,000126,009,00086,892,000
Operating income2,637,425,0002,367,171,0002,080,489,0001,839,324,000
Total other income/expenses (net)-1,189,370,000-951,460,000-863,796,000-646,115,000
Income before tax1,448,055,0001,415,711,0001,216,693,0001,193,209,000
Income tax expense147,812,000206,508,000129,550,000178,241,000
Net income from continuing operations1,300,243,0001,209,203,0001,087,143,0001,014,968,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income1,296,861,0001,197,694,0001,054,973,000996,112,000
Net income deductions0000
Bottom line net income1,296,861,0001,197,694,0001,054,973,000996,112,000
EPS0.790.730.650.58
Diluted EPS0.780.730.620.6
Weighted average shares outstanding1,647,000,0001,649,227,0001,629,994,2311,713,559,218
Weighted average diluted shares outstanding1,658,501,0001,654,988,0001,695,194,0001,653,674,000

Raia Drogasil S.A. Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
3,359,618,000%
Total debt / assets MRQ
—
Period end31/12/202531/12/202431/12/202331/12/2022
Total assets25,473,827,00022,141,690,00020,094,412,00017,185,306,000
Total liabilities18,137,859,00015,699,495,00014,066,111,00011,782,365,000
Total equity7,322,129,0006,428,768,0005,956,001,0005,340,862,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Cash and cash equivalents509,619,000528,002,000412,321,000433,541,000
Short-term investments19,120,00015,706,00000
Cash and short-term investments528,739,000543,708,000412,321,000433,541,000
Net receivables4,678,369,0002,708,647,0003,084,940,0002,295,640,000
Accounts receivable3,400,585,0002,666,760,0003,084,940,0002,295,640,000
Other receivables1,277,784,00041,887,00000
Inventory9,576,343,0008,407,430,0007,197,427,0006,126,056,000
Prepaid expenses116,027,000112,611,00098,855,00061,614,000
Other current assets4,970,000931,316,000768,131,000655,895,000
Total current assets14,904,448,00012,703,712,00011,561,674,0009,577,068,000
Property, plant and equipment (net)7,278,928,0006,546,662,0005,937,687,0005,574,857,000
Goodwill1,086,609,0001,056,628,0001,056,628,0001,085,286,000
Intangible assets964,954,000968,976,000860,625,000652,825,000
Goodwill and intangible assets2,051,563,0002,025,604,0001,917,253,0001,738,111,000
Long-term investments316,148,000265,706,00014,953,0000
Tax assets660,839,000299,325,000010,357,000
Other non-current assets261,901,000300,681,000662,845,000284,913,000
Total non-current assets10,569,379,0009,437,978,0008,532,738,0007,608,238,000
Other assets0000
Total assets25,473,827,00022,141,690,00020,094,412,00017,185,306,000
Total payables6,955,027,0006,472,037,0005,211,193,0004,265,267,000
Accounts payable6,909,199,0005,815,084,0005,091,454,0004,253,815,000
Other payables45,828,000656,953,000119,739,0001,790,000
Accrued expenses567,475,000496,154,000469,375,000398,187,000
Short-term debt1,529,284,000637,110,000604,601,000186,356,000
Capital lease obligations (current)1,021,147,000948,097,000858,467,000759,301,000
Tax payables0396,863,000360,571,000213,298,000
Deferred revenue0000
Other current liabilities1,142,114,0001,166,226,000935,861,000762,616,999
Total current liabilities10,193,900,0009,223,470,0008,079,497,0006,367,168,000
Long-term debt3,359,618,0002,656,820,0002,526,102,0002,131,548,000
Capital lease obligations (non-current)3,945,165,0003,453,188,0003,078,294,0002,980,707,000
Deferred revenue (non-current)0000
Deferred tax liabilities (non-current)303,352,0000017,660,000
Other non-current liabilities335,824,000366,017,000382,218,000285,282,000
Total non-current liabilities7,943,959,0006,476,025,0005,986,614,0005,415,197,000
Other liabilities0000
Capital lease obligations4,966,312,0004,401,285,0003,936,761,0003,740,008,000
Total liabilities18,137,859,00015,699,495,00014,066,111,00011,782,365,000
Treasury stock-104,082,000-124,991,000-67,215,000-80,606,000
Preferred stock0000
Common stock4,750,000,0004,000,000,0004,000,000,0002,500,000,000
Retained earnings283,184,0002,246,426,0001,794,969,000167,526,000
Additional paid-in capital0135,872,000134,007,000134,127,999
Accumulated other comprehensive income/loss2,288,945,000171,461,00094,240,0002,673,336,000
Other stockholders' equity0002,840,862,000
Total stockholders' equity7,322,129,0006,428,768,0005,956,001,0005,340,862,000
Total equity7,335,968,0006,442,195,0006,028,301,0005,402,941,000
Minority interest13,839,00013,427,00072,300,00062,079,000
Total liabilities and total equity25,473,827,00022,141,690,00020,094,412,00017,185,306,000
Total investments335,268,000281,412,00014,953,0000
Total debt8,834,067,0007,695,215,0007,067,464,0006,057,912,000
Net debt8,324,448,0007,167,213,0006,655,143,0005,624,371,000

Raia Drogasil S.A. Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/12/202531/12/202431/12/202331/12/2022
Cash from operations2,430,654,0001,912,580,0001,785,327,0001,682,255,000
Cash from investing-1,405,739,000-1,412,911,000-1,307,123,000-1,229,582,000
Cash from financing-1,043,298,000-383,989,000-499,424,000-375,250,000
Net change in cash-18,382,999115,680,000-21,220,00077,423,000

All line items

Line item31/12/202531/12/202431/12/202331/12/2022
Net income1,296,861,0001,275,031,0001,054,973,0001,193,209,000
Depreciation and amortization2,013,044,000911,965,0001,661,346,0001,515,538,000
Deferred income tax0000
Stock-based compensation27,981,00038,034,00033,215,00022,604,000
Change in working capital-1,004,444,000-111,254,000-2,174,368,000-962,608,000
Accounts receivable-754,225,000463,809,000-892,414,000-652,611,000
Inventory-1,160,865,000-1,235,040,000-1,069,936,000-1,035,341,000
Accounts payable1,104,134,000661,579,000694,460,000728,351,000
Other working capital-193,488,00059,755,000-906,478,000-3,007,000
Other non-cash items125,193,000-201,196,0001,210,161,000-86,488,000
Net cash from operating activities2,430,654,0001,912,580,0001,785,327,0001,682,255,000
Investments in property, plant and equipment-1,402,977,000-1,283,653,000-1,304,581,000-1,188,782,000
Acquisitions (net)652,000-117,817,000-2,696,000-40,000,000
Purchases of investments-3,414,000000
Sales/maturities of investments0000
Other investing activities0-11,441,000154,000-800,000
Net cash from investing activities-1,405,739,000-1,412,911,000-1,307,123,000-1,229,582,000
Net debt issuance536,131,000163,869,000789,173,000791,755,000
Long-term net debt issuance536,131,000163,869,000789,173,000791,754,000
Short-term net debt issuance536,131,00000-842,922,000
Net stock issuance0-73,285,00000
Net common stock issuance0-73,285,00000
Common stock issuance0000
Common stock repurchased0-73,285,00000
Net preferred stock issuance0000
Net dividends paid-652,764,000-474,573,000-465,901,000-324,082,000
Common dividends paid-652,764,000-474,573,000-465,901,000-324,082,000
Preferred dividends paid0000
Other financing activities-926,665,000-474,573,000-822,696,000-842,923,000
Net cash from financing activities-1,043,298,000-383,989,000-499,424,000-375,250,000
Effect of FX changes on cash0000
Net change in cash-18,382,999115,680,000-21,220,00077,423,000
Cash at end of period509,619,000528,002,000412,321,000433,541,000
Cash at beginning of period528,001,999412,322,000433,541,000356,118,000
Operating cash flow2,430,654,0001,912,580,0001,785,327,0001,682,124,000
Capital expenditure-1,402,977,000-1,283,653,000-1,304,581,000-1,188,782,000
Free cash flow1,027,676,999628,927,000480,746,000493,473,000
Income taxes paid0000
Interest paid0000